Nancy J. Hutson has not been actively trading shares of BioCryst Pharmaceuticals in the last ninety days. Most recently, on Monday, May 20th, Nancy J. Hutson bought 5,000 shares of BioCryst Pharmaceuticals stock. The stock was acquired at an average cost of $6.38 per share, with a total value of $31,900.00. Following the completion of the transaction, the director now directly owns 86,818 shares of the company's stock, valued at $553,898.84. Learn More on Nancy J. Hutson's trading history.